Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Publications: Western Australian Centre for Thrombosis and Haemostasis (WACTH)

Export as [feed] RSS
Group by: Item Type | Year
Jump to: 2021 | 2020 | 2019
Number of items at this level: 16.

2021

Baker, R.I. and O’Donnell, J.S. (2021) How I treat bleeding disorder of unknown cause. Blood, 138 (19). pp. 1795-1804.

Casari, I., Manfredi, M., Metharom, P. and Falasca, M. (2021) Dissecting lipid metabolism alterations in SARS-CoV-2. Progress in Lipid Research, 82 . Art. 101092.

Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E., Englert, H., Byrne, M., Bergin, C., O’Sullivan, J.M., Martin‐Loeches, I., Nadarajan, P., Bannan, C., Mallon, P.W., Curley, G.F., Preston, R.J.S., Rehill, A.M., McGonagle, D., Ni Cheallaigh, C., Baker, R.I., Renné, T., Ward, S.E., O’Donnell, J.S., O’Connell, N., Ryan, K., Kenny, D. and Fazavana, J. (2021) Persistent endotheliopathy in the pathogenesis of long COVID syndrome. Journal of Thrombosis and Haemostasis .

Lavin, M., Sánchez Luceros, A., Kouides, P., Abdul‐Kadir, R., O’Donnell, J.S., Baker, R.I., Othman, M. and Haberichter, S.L. (2021) Examining international practices in the management of pregnant women with von Willebrand disease. Journal of Thrombosis and Haemostasis . Early View.

Matasar, M.J., Capra, M., Özcan, M., Lv, F., Li, W., Yañez, E., Sapunarova, K., Lin, T., Jin, J., Jurczak, W., Hamed, A., Wang, M-C, Baker, R., Bondarenko, I., Zhang, Q., Feng, J., Geissler, K., Lazaroiu, M., Saydam, G., Szomor, Á., Bouabdallah, K., Galiulin, R., Uchida, T., Soler, L.M., Cao, A., Hiemeyer, F., Mehra, A., Childs, B.H., Shi, Y. and Zinzani, P.L. (2021) Abstract CT001: CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL). Cancer Research, 81 (13 Suppl.). CT001.

Tian, J.ORCID: 0000-0001-9887-7211, Adams, M.J.ORCID: 0000-0002-7743-4515, Tay, J.W.T., James, I., Powell, S., Hughes, Q.W., Gilmore, G., Baker, R.I. and Tiao, J.Y-H. (2021) Estradiol-responsive miR-365a-3p interacts with tissue factor 3′UTR to modulate tissue factor-initiated thrombin generation. Thrombosis and Haemostasis, 121 (11). pp. 1483-1496.

Ward, S.E., Fogarty, H., Karampini, E., Lavin, M., Schneppenheim, S., Dittmer, R., Morrin, H., Glavey, S., Ni Cheallaigh, C., Bergin, C., Martin‐Loeches, I., Mallon, P.W., Curley, G.F., Baker, R.I., Budde, U., O’Sullivan, J.M., O’Donnell, J.S., O’Connell, N., Byrne, M., Townsend, L., McEvoy, N.L., Clarke, J., Boylan, M., Alalqam, R., Worrall, A.P., Kelly, C., de Barra, E., Preston, R. and Kenny, D. (2021) ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19. Journal of Thrombosis and Haemostasis . Early View.

Zinzani, P.L., Capra, M., Özcan, M., Lv, F., Li, W., Yañez, E., Sapunarova, K., Lin, T., Jin, J., Jurczak, W., Hamed, A., Wang, M.C., Baker, R., Bondarenko, I., Zhang, Q., Feng, J., Geissler, K., Lazaroiu, M., Saydam, G., Szomor, Á., Bouabdallah, K., Galiulin, R., Uchida, T., Mongay Soler, L., Cao, A., Hiemeyer, F., Mehra, A., Childs, B.H., Shi, Y. and Matasar, M.J. (2021) CHRONOS‐3: Randomized phase III study of copanlisib plus rituximab/placebo in relapsed indolent Non-Hodgkin Lymphoma (INHL). Hematological Oncology, 39 (S2).

2020

Elaskalani, O., Domenichini, A., Abdol Razak, N., E. Dye, D., Falasca, M. and Metharom, P. (2020) Antiplatelet drug ticagrelor enhances chemotherapeutic efficacy by targeting the novel P2Y12-AKT Pathway in pancreatic cancer cells. Cancers, 12 (1). Art. 250.

Favaloro, E.J., Gilmore, G., Bonar, R., Dean, E., Arunachalam, S., Mohammed, S. and Baker, R. (2020) Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference. Clinical Chemistry and Laboratory Medicine, 58 (8).

Favaloro, E.J., Gilmore, G., Bonar, R., Dean, E., Arunachalam, S., Mohammed, S. and Baker, R. (2020) Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects. Haemophilia . Early View.

Mackie, I., Mancini, I., Muia, J., Kremer Hovinga, J., Nair, S., Machin, S. and Baker, R. (2020) International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13. International Journal of Laboratory Hematology . Early View.

Tiao, J., Powell, S., Gilmore, G., Veedu, R., Wilton, S. and Baker, R. (2020) Splice inducing Antisense Oligonucleotides as a potential gene correction therapy for haemophilia A. Haemophilia, 26 (S4). pp. 21-22.

2019

Favaloro, E., Gilmore, G., Arunachalam, S., Mohammed, S. and Baker, R. (2019) Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa. Thrombosis Research, 180 . pp. 10-19.

Ho, K.M., Rao, S., Honeybul, S., Zellweger, R., Wibrow, B., Lipman, J., Holley, A., Kop, A., Geelhoed, E., Corcoran, T., Misur, P., Edibam, C., Baker, R.I., Chamberlain, J., Forsdyke, C. and Rogers, F.B. (2019) A multicenter Trial of Vena Cava filters in severely injured patients. New England Journal of Medicine, 381 (4). pp. 328-337.

Oh, J., Oh, D., Lee, S.J., Kim, J.H., Kim, N.K., Chong, S.Y., Huh, J.Y. and Baker, R.I. (2019) Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura. Blood Research, 54 (3). pp. 218-228.

This list was generated on Wed May 18 04:17:12 2022 UTC.